Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
43
Recruiting, any sponsor type, condition "urinary tract infection"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed241
43 trials
Showing 1 to 25, recently updated first.
- Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract InfectionsPivotal-lookingRecruiting
Atlantic Health SystemAcademic, hospital or other
NCT04285320 · 100 participants (planned) · Start Jun 11, 2021 · Primary completion Jun 2027
Drug: Intravesical antibiotic instillation; Antibiotic oral suppressive therapy · For: Recurrent Urinary Tract Infection
Sites: Morristown, New Jersey
- Prophylactic Antibiotics for Outpatient Urethral BulkingPivotal-lookingRecruiting
University of MiamiAcademic, hospital or other
NCT07501065 · 150 participants (planned) · Start Aug 19, 2026 · Primary completion Jun 2028
Drug: Bactrim (800/160 mg), Keflex (500 mg), Cipro (250 mg), or Macrobid (100mg) · For: Urinary Tract Infections; Stress Urinary Incontinence; Urinary Incontinence
Sites: Miami, Florida · 2 sites in all
University College, LondonAcademic, hospital or other
NCT07202949 · 192 participants (planned) · Start Feb 26, 2026 · Primary completion Oct 2027
Drug: Treatment dose antibiotic in combination with methenamine hippurate; Prophylactic dose antibiotic or methenamine hippurate monotherapy · For: Chronic Urinary Tract Infection
Sites: Yorkshire, United Kingdom; London, United Kingdom; Manchester, United Kingdom · 5 sites in all
- Precision Management of Urinary Tract Symptoms in Older WomenPivotal-lookingRecruiting
Megan BradleyAcademic, hospital or other
NCT07686055 · 90 participants (planned) · Start Jul 23, 2026 · Primary completion Feb 1, 2027
Drug: Antibiotics · For: Urinary Tract Infection (Diagnosis)
Sites: Pittsburgh, Pennsylvania
- Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)Pivotal-lookingRecruiting
Ohio State UniversityAcademic, hospital or other
NCT06706362 · 138 participants (planned) · Start Sep 15, 2025 · Primary completion Apr 15, 2027
Drug: Bactrim or Macrobid; Placebo · For: Stress Urinary Incontinence
Sites: Columbus, Ohio
- Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in ChildrenPivotal-lookingRecruiting
Murdoch Childrens Research InstituteAcademic, hospital or other
NCT04876131 · 396 participants (planned) · Start May 30, 2022 · Primary completion Jan 2028
Drug: Benzylpenicillin - single dose; Benzylpenicillin - three days and 3 more · For: Complicated Urinary Tract Infection; Infection; Pediatric Infectious Disease
Sites: Adelaide, Australia; Geelong, Australia; Melbourne, Australia · 7 sites in all
Menarini GroupIndustry
NCT06828848 · 44 participants (planned) · Start Feb 18, 2025 · Primary completion Oct 2027
Drug: Meropenem plus vaborbactam · For: Gram Negative Infections
Sites: Ostrava, Czechia; Prague, Czechia; Nantes, France · 22 sites in all
University of ArizonaAcademic, hospital or other
NCT06814496 · 30 participants (planned) · Start Sep 8, 2025 · Primary completion May 2030
Drug: Tarlatamab · For: Melanoma; Medullary Thyroid Cancer; Sinonasal Undifferentiated Carcinoma and 8 more
Sites: Gilbert, Arizona; Tucson, Arizona; Seattle, Washington
- Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in WomenPivotal-lookingRecruiting
TCM Biotech International Corp.Industry
NCT07184827 · 348 participants (planned) · Start Oct 14, 2020 · Primary completion Jun 30, 2028
Drug: U101 · For: Recurrent Urinary Tract Infections in Women
Sites: Chiayi City, Taiwan; Douliu, Taiwan; Kaohsiung City, Taiwan · 18 sites in all
GlaxoSmithKlineGSK (GSK)
NCT07645235 · 8 participants (planned) · Start Jul 23, 2026 · Primary completion May 17, 2027
Drug: Gepotidacin · For: Urinary Tract Infections
Sites: Las Vegas, Nevada
Mayo ClinicAcademic, hospital or other
NCT07285044 · 27 participants (planned) · Start Dec 18, 2025 · Primary completion May 15, 2027
Drug: Cancer Therapeutic Procedure; Cancer Therapeutic Procedure · For: Amyloidosis; Basal Cell Carcinoma; Biliary Tract Carcinoma and 26 more
Sites: Jacksonville, Florida
- Antibiotic Prophylaxis for Bladder BotoxPivotal-lookingRecruiting
University of AlbertaAcademic, hospital or other
NCT04444440 · 202 participants (planned) · Start Jun 28, 2021 · Primary completion Jun 30, 2028
Drug: Ciprofloxacin · For: Idiopathic Overactive Bladder; Postoperative Urinary Tract Infection
Sites: Edmonton, Canada
- A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)Pivotal-lookingRecruiting
Locus BiosciencesIndustry
NCT05488340 · 318 participants (planned) · Start Jul 13, 2022 · Primary completion Jun 2027
Drug: LBP-EC01 0.1 x IV dose; LBP-EC01 0.01x IV Dose and 4 more · For: Urinary Tract Infections
Sites: Fresno, California; Lancaster, California; Los Angeles, California · 17 sites in all
Antonios LikourezosAcademic, hospital or other
NCT05227937 · 75 participants (planned) · Start Sep 21, 2022 · Primary completion May 31, 2026
Drug: Amikacin · For: Urinary Tract Infections
Sites: Brooklyn, New York
- Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic BladderPivotal-lookingRecruiting
Centre Hospitalier Universitaire DijonAcademic, hospital or other
NCT06588010 · 110 participants (planned) · Start Dec 16, 2024 · Primary completion Dec 2029
Drug: OM-89 [Uro-Vaxom® Capsule]; OM-89 [Uro-Vaxom® Capsule] OM-89 placebo [Uro-Vaxom® Capsule placebo] · For: Neurogenic Bladder
Sites: Dijon, France
Duke UniversityAcademic, hospital or other
NCT04278404 · 5,000 participants (planned) · Start Mar 5, 2020 · Primary completion Nov 2026
Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: · For: Coronavirus Infection (COVID-19); Pulmonary Arterial Hypertension; Urinary Tract Infections in Children and 22 more
Sites: Phoenix, Arizona; Little Rock, Arkansas; Los Angeles, California · 52 sites in all
- Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'Pivotal-lookingRecruiting
Murdoch Childrens Research InstituteAcademic, hospital or other
NCT07532941 · 200 participants (planned) · Start Aug 18, 2026 · Primary completion Jun 2028
Drug: Antibiotics for duration of symptoms; Antibiotics for duration of prescribed course · For: Urinary Tract Infection; Cellulitis; Respiratory Tract Infections and 1 more
Sites: Melbourne, Australia
Orchid Pharma Europe GmbHIndustry
NCT05826990 · 40 participants (planned) · Start Sep 11, 2023 · Primary completion May 21, 2029
Drug: cefepime and enmetazobactam combination · For: Complicated Urinary Tract Infection
Sites: Hradec Králové, Czechia; Kolín, Czechia; Toulouse, France · 8 sites in all
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionPivotal-lookingRecruiting
Women and Infants Hospital of Rhode IslandAcademic, hospital or other
NCT06953271 · 164 participants (planned) · Start Aug 1, 2025 · Primary completion Jan 30, 2027
Drug: Methenamine Hippurate; Typically prescribed oral antibiotic prophylaxis · For: Overactive Bladder (OAB); Urinary Tract Infection (Diagnosis)
Sites: Providence, Rhode Island
Marengo Therapeutics, Inc.Industry
NCT05592626 · 366 participants (planned) · Start Jan 4, 2023 · Primary completion Sep 2027
Drug: STAR0602 · For: Advanced Solid Tumors; Genital Neoplasm, Female; Urogenital Neoplasms and 11 more
Sites: Sacramento, California; Celebration, Florida; Miami, Florida · 19 sites in all
Baylor College of MedicineAcademic, hospital or other
NCT07508124 · 40 participants (planned) · Start May 8, 2026 · Primary completion Dec 2027
Drug: betamethasone valerate 0.1% cream; Placebo cream · For: Urinary Tract Infection
Sites: Houston, Texas; Katy, Texas; Seattle, Washington
- IDOV-Immune for Advanced Solid TumorsRecruiting
ViroMissile, Inc.Industry
NCT06910657 · 78 participants (planned) · Start Aug 25, 2025 · Primary completion Jan 31, 2027
Drug: IDOV-Immune (oncolytic vaccinia virus) · For: Colorectal Cancer; Pancreatic Cancer; Melanoma and 13 more
Sites: St Louis, Missouri; Houston, Texas; San Antonio, Texas · 5 sites in all
- Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract InfectionsPivotal-lookingRecruiting
University of Texas Southwestern Medical CenterAcademic, hospital or other
NCT06907199 · 104 participants (planned) · Start Apr 6, 2026 · Primary completion Jul 1, 2028
Drug: Nitrofurantoin (NF) · For: Recurrent UTIs; Cystitis Recurrent
Sites: Kansas City, Kansas; Dallas, Texas
- Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRSPivotal-lookingRecruiting
Hitit UniversityAcademic, hospital or other
NCT07655050 · 180 participants (planned) · Start Jun 15, 2026 · Primary completion Feb 8, 2027
Drug: Gentamicin Irrigation · For: Kidney Calculi; Urolithiasis; Urinary Tract Infections
Sites: Çorum, Turkey (Türkiye) · 2 sites in all
- Antibiotic Prophylaxis for Neurogenic Bladder BotoxPivotal-lookingRecruiting
University of AlbertaAcademic, hospital or other
NCT04791579 · 160 participants (planned) · Start Feb 1, 2025 · Primary completion Mar 31, 2027
Drug: Ciprofloxacin; Placebo · For: Neurogenic Bladder; Post-operative Urinary Tract Infections
Sites: Edmonton, Canada
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.